Keywords: cytogen, quadramet, efficacy, tumors, new, clinical, data

Cytogen's Quadramet efficacy in tumors

Article | 16 June 2003

New clinical data presented at the American Society of Oncology meeting in Chicago demonstrate synergies of Cytogen's Quadramet (samarium Sm 153 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Go to company listing

Related Drugs

Quadramet

Samarium SM 153 Lexidronam

Amino Acids

Injection

docetaxel

Go to drug listing